Effects of golimumab, an anti-tumour necrosis factor-α human monoclonal antibody, on lipids and markers of inflammation

No significant changes in arterial stiffness in patients with ankylosing spondylitis after tumour necrosis factor alpha blockade treatment for 6 and 12 months

(2012) S. Mathieu et al.   RHEUMATOLOGY

The effect of pharmacological therapy on the cardiovascular system of patients with systemic rheumatic diseases

(2010) Fabiola Atzeni et al.   AUTOIMMUNITY REVIEWS

A systematic review of the effect of TNF-α antagonists on lipid profiles in patients with rheumatoid arthritis

(2010) Eduardo Nicolas Pollono et al.   CLINICAL RHEUMATOLOGY

Clinical Improvement in Rheumatoid Arthritis Is Associated with Healthier Microvascular Function in Patients Who Respond to Antirheumatic Therapy

(2010) B. GALARRAGA et al.   JOURNAL OF RHEUMATOLOGY

Total cholesterol and LDL levels decrease before rheumatoid arthritis

(2009) E. Myasoedova et al.   ANNALS OF THE RHEUMATIC DISEASES

Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions

(2009) E Choy et al.   ANNALS OF THE RHEUMATIC DISEASES

The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double-blind, placebo-controlled phase IIa trial of three dosage levels of CP-690,550 versus placebo

(2009) Joel M. Kremer et al.   ARTHRITIS AND RHEUMATISM

Golimumab, a human anti-tumor necrosis factor α monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naive patients with active rheumatoid arthritis: Twenty-four-week results of a phase III, multicenter, randomized, double-blind, placebo-controlled study of golimumab before methotrexate as first-line therapy for early-onset rheumatoid arthritis

(2009) Paul Emery et al.   ARTHRITIS AND RHEUMATISM

Effects of rituximab treatment on endothelial dysfunction, carotid atherosclerosis, and lipid profile in rheumatoid arthritis

(2009) György Kerekes et al.   CLINICAL RHEUMATOLOGY

Effects of the anti-interleukin-6 receptor antibody, tocilizumab, on serum lipid levels in patients with rheumatoid arthritis

(2009) Shin-ya Kawashiri et al.   RHEUMATOLOGY INTERNATIONAL

Sustained changes in lipid profile and macrophage migration inhibitory factor levels after anti-tumour necrosis factor therapy in rheumatoid arthritis

(2008) C A Wijbrandts et al.   ANNALS OF THE RHEUMATIC DISEASES

Golimumab, a human antibody to tumour necrosis factor   given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study

(2008) E C Keystone et al.   ANNALS OF THE RHEUMATIC DISEASES

Lipoprotein Management in Patients With Cardiometabolic Risk: Consensus statement from the American Diabetes Association and the American College of Cardiology Foundation

(2008) J. D. Brunzell et al.   DIABETES CARE

Cardiovascular risk in rheumatoid arthritis: effects of anti-TNF drugs

(2008) J Avouac et al.   EXPERT OPINION ON PHARMACOTHERAPY

Effects of anti-tumor necrosis factor therapy on lipid profile in patients with rheumatoid arthritis

(2007) Martin Soubrier et al.   JOINT BONE SPINE